Literature DB >> 22966344

MicroRNA-mediated regulation of pancreatic cancer cell proliferation.

Aruna Basu1, Xin Jiang, Massimo Negrini, Subrata Haldar.   

Abstract

MicroRNAs (miRNAs) comprising 19-25 nucleotides are highly conserved small non-coding RNAs which regulate normal gene expression during development, cell proliferation and apoptosis by targeting mRNAs of protein-coding genes at the post-transcriptional level. Prevalent studies suggest that some human miRNAs, such as miRNA-16, are deregulated in human cancer and behave as tumor suppressors. The overall objective of our investigation was to assess whether miRNA-16 (miR-16) is involved in the regulation of critical genes, such as BCL2, that control the sensitivity of pancreatic cancer cells to apoptosis. This study showed that the ectopic overexpression of miR-16 may be therapeutically beneficial as is evidenced by impaired cell survival with concomitant attenuation of anti-apoptotic protein Bcl-2. Moreover, the luciferase reporter assay suggested that miR-16 post-transcriptionally regulates Bcl-2 expression in pancreatic cancer cells through the target sites of the 3' untranslated region of this gene.

Entities:  

Year:  2010        PMID: 22966344      PMCID: PMC3436255          DOI: 10.3892/ol_00000100

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

Review 1.  Principles of micro-RNA production and maturation.

Authors:  Y Zeng
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

Review 2.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

3.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

4.  miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.

Authors:  Lin Xia; Dexin Zhang; Rui Du; Yanglin Pan; Lina Zhao; Shiren Sun; Liu Hong; Jie Liu; Daiming Fan
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

5.  Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.

Authors:  Wing Pui Tsang; Tim Tak Kwok
Journal:  J Nutr Biochem       Date:  2009-03-09       Impact factor: 6.048

6.  Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors:  Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

Review 7.  The let-7 family of microRNAs.

Authors:  Sarah Roush; Frank J Slack
Journal:  Trends Cell Biol       Date:  2008-09-04       Impact factor: 20.808

Review 8.  MicroRNAs and cancer--new paradigms in molecular oncology.

Authors:  Massimo Negrini; Milena S Nicoloso; George A Calin
Journal:  Curr Opin Cell Biol       Date:  2009-05-04       Impact factor: 8.382

9.  MicroRNAs modulate the chemosensitivity of tumor cells.

Authors:  Paul E Blower; Ji-Hyun Chung; Joseph S Verducci; Shili Lin; Jong-Kook Park; Zunyan Dai; Chang-Gong Liu; Thomas D Schmittgen; William C Reinhold; Carlo M Croce; John N Weinstein; Wolfgang Sadee
Journal:  Mol Cancer Ther       Date:  2008-01-09       Impact factor: 6.261

10.  MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.

Authors:  Joanne B Weidhaas; Imran Babar; Sunitha M Nallur; Phong Trang; Sarah Roush; Michelle Boehm; Erin Gillespie; Frank J Slack
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

View more
  6 in total

1.  Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage.

Authors:  Subrata Haldar; Aruna Basu
Journal:  Mol Cell Pharmacol       Date:  2011-01-01

2.  MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer.

Authors:  Aruna Basu; Hansjuerg Alder; Amer Khiyami; Patrick Leahy; Carlo M Croce; Subrata Haldar
Journal:  Genes Cancer       Date:  2011-02

3.  microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K/Akt/mTOR pathway.

Authors:  Xin Huang; Xuan Xu; Huajing Ke; Xiaolin Pan; Jiaoyu Ai; Ruyi Xie; Guilian Lan; Yang Hu; Yao Wu
Journal:  Eur J Histochem       Date:  2022-05-10       Impact factor: 1.966

4.  Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.

Authors:  R Venkatadri; T Muni; A K V Iyer; J S Yakisich; N Azad
Journal:  Cell Death Dis       Date:  2016-02-18       Impact factor: 8.469

5.  The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies.

Authors:  Martina Remakova; Tana Svitalkova; Marek Skoda; Jiri Vencovsky; Peter Novota
Journal:  F1000Res       Date:  2013-10-23

6.  Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.

Authors:  Bishnupriya Chhatriya; Moumita Mukherjee; Sukanta Ray; Piyali Sarkar; Shatakshee Chatterjee; Debashis Nath; Kshaunish Das; Srikanta Goswami
Journal:  BMC Cancer       Date:  2019-12-03       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.